0.8016
前日終値:
$0.8451
開ける:
$0.866
24時間の取引高:
137.08K
Relative Volume:
0.73
時価総額:
$31.28M
収益:
$135.87M
当期純損益:
$72.20M
株価収益率:
0.5645
EPS:
1.42
ネットキャッシュフロー:
$45.09M
1週間 パフォーマンス:
-8.39%
1か月 パフォーマンス:
-2.12%
6か月 パフォーマンス:
-28.43%
1年 パフォーマンス:
-51.42%
Scynexis Inc Stock (SCYX) Company Profile
SCYX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
SCYX
Scynexis Inc
|
0.8016 | 32.98M | 135.87M | 72.20M | 45.09M | 1.42 |
![]()
ZTS
Zoetis Inc
|
153.06 | 67.56B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.80 | 46.65B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.70 | 43.48B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.54 | 19.74B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
312.06 | 14.01B | 2.99B | 1.21B | 1.13B | 25.06 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2021-01-22 | 開始されました | Guggenheim | Buy |
2021-01-06 | 開始されました | Cantor Fitzgerald | Overweight |
2018-07-11 | アップグレード | Needham | Hold → Buy |
2018-06-27 | 開始されました | Maxim Group | Buy |
2017-10-24 | 開始されました | Guggenheim | Buy |
2017-07-10 | 開始されました | ROTH Capital | Buy |
2017-05-09 | ダウングレード | Needham | Buy → Hold |
2017-03-03 | 繰り返されました | RBC Capital Mkts | Outperform |
2016-10-20 | 開始されました | H.C. Wainwright | Buy |
2016-10-07 | アップグレード | WBB Securities | Buy → Strong Buy |
2016-10-03 | 再開されました | Brean Capital | Buy |
2016-08-17 | 開始されました | Guggenheim | Buy |
2016-08-09 | 繰り返されました | Needham | Buy |
2016-08-09 | アップグレード | WBB Securities | Speculative Buy → Buy |
2016-03-28 | 開始されました | Brean Capital | Buy |
2015-12-29 | 開始されました | WBB Securities | Speculative Buy |
2015-11-16 | 繰り返されました | RBC Capital Mkts | Outperform |
2015-06-10 | 開始されました | Needham | Buy |
2014-05-29 | 開始されました | Canaccord Genuity | Buy |
2014-05-29 | 開始されました | RBC Capital Mkts | Outperform |
すべてを表示
Scynexis Inc (SCYX) 最新ニュース
Key metrics from SCYNEXIS Inc.’s quarterly dataTreasury Yields & Real-Time Chart Pattern Alerts - Newser
Scynexis 2025 Q2 Earnings Significant Loss Reduction - AInvest
Is SCYNEXIS Inc. stock poised for growthCEO Change & Short-Term Trading Opportunity Alerts - Newser
Sector ETF performance correlation with SCYNEXIS Inc.2025 Big Picture & Long-Term Growth Stock Strategies - Newser
Why SCYNEXIS Inc. stock attracts strong analyst attentionJuly 2025 Short Interest & AI Powered Market Entry Strategies - Newser
Can SCYNEXIS Inc. hit a new high this monthJuly 2025 WrapUp & Low Volatility Stock Suggestions - Newser
How high can SCYNEXIS Inc. stock goPrice Action & Growth Focused Investment Plans - Newser
What’s next for SCYNEXIS Inc. stock priceJuly 2025 Rallies & Safe Capital Allocation Plans - Newser
Scynexis: Q2 Earnings Snapshot - Stamford Advocate
SCYNEXIS Reports Improved Financials Amidst Strategic Developments - TipRanks
Will a bounce in SCYNEXIS Inc. offer an exitTrade Entry Report & Fast Entry High Yield Stock Tips - Newser
SCYNEXIS Inc. Advances Phase 3 Study for Invasive Candidiasis Treatment - MSN
SCYNEXIS Inc. Earnings Report Breakdown: What Investors Should KnowMarket Movement Recap & Safe Entry Momentum Tips - Newser
Scynexis Inc earnings beat by $0.06, revenue topped estimates - Investing.com India
Scynexis reports Q2 EPS (14c), consensus (19c) - TipRanks
SCYNEXIS Doses First Patient in Phase 3 MARIO Study, $10M Milestone Payment Triggered Amid Ongoing Dispute with GSK - Quiver Quantitative
SCYNEXIS Restarts Key Phase 3 Trial but Faces Payment Dispute with Partner GSK over $30M Milestone - Stock Titan
SCYNEXIS Inc. stock trend forecastJuly 2025 Institutional & High Win Rate Trade Tips - Newser
Historical volatility pattern of SCYNEXIS Inc. visualizedQuarterly Trade Review & Capital Efficient Trade Techniques - Newser
Price momentum metrics for SCYNEXIS Inc. explainedWeekly Trade Recap & High Return Trade Opportunity Guides - Newser
SCYNEXIS Inc. stock retracement – recovery analysis2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - Newser
Can SCYNEXIS Inc. hit a new high this month [Weekly Trading Summary]Weekly Chart Analysis and Trade Guides - Newser
Using Python tools to backtest SCYNEXIS Inc. strategiesMarket Activity Report & Weekly Chart Analysis and Guides - Newser
Chartists See Breakout Potential in SCYNEXIS Inc.Low Risk Swing Trade Opportunities Identified - 선데이타임즈
Published on: 2025-08-11 23:14:27 - Newser
Technical analysis overview for SCYNEXIS Inc. stockFree Fundamental Winners With Safe Entry Plan - Newser
Reviewing CytoDyn (OTCMKTS:CYDY) & SCYNEXIS (NASDAQ:SCYX) - Defense World
What candlestick patterns are forming on SCYNEXIS Inc.Triple Digit Gain Opportunity Watchlist - Newser
Top chart patterns to watch in SCYNEXIS Inc.Secure Asset Flow and Trend Pattern Analysis - Newser
Real time scanner hits for SCYNEXIS Inc. explainedAI-Powered Stock Trend Movement Analysis - Newser
Applying big data sentiment scoring on SCYNEXIS Inc.Short-Term Upside Breakout Forecast System - Newser
Volatility clustering patterns for SCYNEXIS Inc.AI Short-Term Gain Forecast with Data - Newser
Scynexis Inc (SCYX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):